BNP PARIBAS ARBITRAGE/PUT/ELI LILLY & CO/750/0.01/20.12.24 | Market Closed - Borsa Italiana 01:34:59 29/06/2024 am IST | ||
| 0.1815 EUR | +0.83% |
|
| Current month | -53.50% | ||
| 1 month | -57.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 0.1725 | -4.17% |
| 27/24/27 | 0.18 | -5.76% |
| 26/24/26 | 0.191 | +2.96% |
| 25/24/25 | 0.1855 | -6.78% |
| 24/24/24 | 0.199 | -7.01% |
Real-time Borsa Italiana
Last update June 29, 2024 at 01:34 am IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
BNP Paribas
|
| P22TC3 | |
| ISIN | NLBNPIT22TC3 |
| Date issued | 08/05/2024 |
| Strike | 750 $ |
| Maturity | 20/12/2024 (174 Days) |
| Parity | 100 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.634 € |
|---|---|
| Lowest since issue | 0.1705 € |
| Delta | -0.16x |
| Omega | 7.212 |
| Premium | 19.32x |
| Gearing | 46.32x |
| Moneyness | 0.8284 |
| Difference Strike | -155.4 $ |
| Difference Strike % | -20.72% |
| Spread | 0.03 € |
| Spread % | 15.19% |
| Theoretical value | 0.1825 |
| Implied Volatility | 34.24 % |
| Total Loss Probability | 78.04 % |
| Intrinsic value | 0.000000 |
| Present value | 0.1825 |
| Break even | 730.46 € |
| Theta | -0.01x |
| Vega | 0.01x |
| Rho | -0.01x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4
USD
Average target price
868.9
USD
Spread / Average Target
-4.03%
- Stock Market
- Warrants
- P22TC3 Warrant
